NCT00615030 - Study of Indacaterol Dosed in the Evening in Patients With Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

July 31, 2008

Study Completion Date

August 31, 2008

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG

Indacaterol

300 µg dosed in the morning/evening via single dose dry powder inhaler (SDDPI)

DRUG

Salmeterol

50 µg twice daily delivered via dry powder inhaler (DPI)

DRUG

Placebo to Indacaterol

Placebo matching indacaterol was delivered via SDDPI.

DRUG

Placebo to Salmeterol

Placebo matching salmeterol was delivered via DPI

Trial Locations (7)

Novartis Investigative Site, Beuvry

Novartis Investigative Site, Nantes

Novartis Investigative Site, Berlin

Novartis Investigative Site, Hamburg

Novartis Investigative Site, Leipzig

Novartis Investigative Site, Mainz

Novartis Investigative Site, Barcelona